Fred Lublin, MD

img_Fred Lublin
PROFESSOR | Neurology
Are you a patient?
Specialties
Neurology
Neuroimmunology
Basic and translational neuroimmunology
Multiple Sclerosis
Clinical trials in MS and other demyelination disorders

MD, Thomas Jefferson University, Sidney Kimmel Medical College

Internship, Internal Medicine, Albert Einstein College of Medicine-Yeshiva University

Residency, Neurology, New York Presbyterian Hospital-Weill Cornell

Residency, Neurology, Weill Medical College of Cornell University

Certifications

American Board of Psychiatry and Neurology

2025

June Halper Visionary Award

Consortium of Multiple Sclerosis Centers

2019

Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis

AcademicCME, Advanced Curriculum for Multiple Sclerosis

2019

June Halpern Lifetime Achievement Award

Consortium of Multiple Sclerosis Centers

2019

Presidential Lecture

Consortium of Multiple Sclerosis Centers

2017

Clifford Goldsmith Award

Icahn School of Medicine at Mount Sinai

2017

Honorary Member of the French Society of Neurology

Societe Francaise de Neurologie

2013

Award of Appreciation for Outstanding Academic Teaching

Icahn School of Medicine at Mount Sinai

2001

Attending of the Year Award

Mount Sinai Medical Center Neurology Residents

2000

Chairman, Research Programs Advisory Committee

National Multiple Sclerosis Society

1999

McEwan Visiting Professorship & Lecture in Neurology

University of Toronto

1999

Hope Award

National Multiple Sclerosis Society, Delaware Valley Chapter

1996

Milestone Award

National Multiple Sclerosis Society, Delaware Valley Chapter

Publications

Selected Publications

Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years. Tomas Olsson, Xavier Montalban, Reinhard Hohlfeld, Carlo Pozzilli, Mark S. Freedman, Till Sprenger, Robert J. Fox, Eva Kubala Havrdova, Fred Lublin, Nandini Raghavan, Janice Wong, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Amita Singh, Michel Burcklen, Ludwig Kappos. Multiple Sclerosis and Related Disorders

Staying afloat with OCEAN traits: The five-factor model of personality and psychological resilience in multiple sclerosis. Claire E. Wigley, Jonadab dos Santos Silva, Nicole Graziano, Claire Riley, Jonathan Howard, Matilde Inglese, Fred D. Lublin, Melissa Milanak, Sylvia Klineova. Multiple Sclerosis and Related Disorders

Towards a biologically informed description of multiple sclerosis disease course — a roadmap for transition. Alan J. Thompson, Fred D. Lublin, Lindsay Rechtman, James Quinn, Maria Pia Amato, Bruce Bebo, Peter A. Calabresi, Julie Fiol, Marcia Finlayson, Annie Hawton, Tanja Kuhlmann, Ruth Ann Marrie, Marcello Moccia, Xavier Montalban, Michael Panzara, Kathy Smith, Maria Pia Sormani, Jon Strum, Barbara G. Vickrey, Timothy Coetzee, Paola Zaratin, Anneke van der Walt, Helen Tremlett, Mar Tintoré, Bruno Stankoff, Andrew Solomon, Amber Salter, Mara Rocca, Daniel Reich, Sudarshini Ramanathan, Daniel Ontaneda, Jiwon Oh, Aaron Miller, Christine Lebrun-Frénay, Daphne Kos, Dorlan Kimbrough, Joep Killestein, Kerstin Hellwig, Cristina Granziera, Kazuo Fujihara, Jorge Correale, Olga Ciccarelli, Jeremy Chataway, Helmut Butzkueven, Amit Bar-Or, Frederik Barkhof, Brenda Banwell, Lilyana Amezcua. Nature Reviews Neurology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Lublin during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Immunic
  • Amgen
  • InnoCare Pharma
  • Viatris
  • Kite Pharma
  • Latham & Watkins LLP
  • Centessa Pharmaceuticals
  • Rupp Pfalzgraf
  • Novartis Pharmaceutical Corporation
  • Gibson Dunn
  • Clene
  • DLA Piper
  • AbbVie, Inc.
  • Sanofi Genzyme
  • Nurix Therapeutics
  • Cooper Levenson
  • Setpoint Medical
  • Venable LLP
  • Neuralight, Inc.
  • Bristol-Myers Squibb
  • Liad Whatstein & Co.
  • Zenas BioPharma
  • Avotres Inc.
  • Wilmer Hale Law Firm
  • Ardanza Biopharma AG
  • EMD Serono, Inc
  • Autolus Limited UK
  • Sudo Biosciences

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Avotres Inc.
  • Neuralight, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.